From: Sub-typing of renal cell tumours; contribution of ancillary techniques
 | CCRCC | PRCC | CRCC | RO | CDC | UNCLASSIFIED |
---|---|---|---|---|---|---|
Present Study(India) | 208 (74.8%) | 34(12.2%) | 22(7.9%) | 5(1.8%) | 1(0.5%) | - |
Srivastva et al[17](India) | 114 (64.0%) | 48 (27.0%) | 14 (7.86%) | - | 2 (1.12%) | - |
Zou et al[12](China) | 77(67.5%) | 11(9.6%) | 14(12.3%) | - | - | 2(1.8%) |
Patard et al[13](France) | 3564(87.7%) | 396(9.7%) | 103(2.5%) | - | - | - |
Kim et al[14](Korea) | 686(86.3%) | 58(7.3%) | 49(6.16%) | - | 2(0.25%) | - |
Gudbjartsson et al[15](Iceland) | 558(88.7%) | 53(8.4%) | 13(2.1%) | - | - | - |
Kovacs et al[6](Japan) | 80% | 10% | 5% | 5% | - | - |
Amin et al[16](USA) | 255(63%) | 75(18.5%) | 24(5.9%) | - | - | 23(5.7%) |